Back

Unmasking the supernormal: intrinsic cardiomyopathy drives poor outcomes in heart failure with supranormal ejection fraction

30 August 2026 (17:00 - 17:10)
Organised by: Logo
Congress Presentation Part of: Drivers of heart failure with preserved ejection fraction Heart Failure with Preserved Ejection Fraction (HFpEF) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Yanjia Chen

Rui Jin Hospital- Shanghai Jiaotong University School of Medicine, Shanghai (China)

5 More presentations in this session

Presentation thumbnail
Time-series analysis of the chronotropic response and its association with HFpEF risk scoring and adverse events
Doctor M. Vermeiren (Leuven, BE) Professor P. Sinnaeve (Leuven, BE)
Abstract Slides Video
Presentation thumbnail
Association between LDL-C levels and outcomes in patients with heart failure with preserved ejection fraction: a real-world study
Doctor S. Jiang (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Time in blood pressure range and cardiovascular outcomes in HFmrEF/HFpEF: a pooled participant-level analysis of four large-scale trials
Doctor H. Lu (Lausanne, CH)
Abstract Slides Video
Presentation thumbnail
FKBP11 drives cardiomyocyte ferroptosis in HFpEF by destabilizing GPX4 via proteasomal degradation.
Mr Z. Li (CN)
Abstract Slides Video
Presentation thumbnail
Bridging sex differences in HFpEF diagnosis: enhanced predictive performance of the H2FPEF score by incorporating BNP and stepwise E/e′
Doctor J. Weber (Duesseldorf, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Drivers of heart failure with preserved ejection fraction
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 17:00 CET
You may be interested in
thumbnail
Congress Presentation
Hypercontractile phenotype of the left ventricle in patients with heart failure with preserved ejection fraction: too strong to be normal?
12 December 2024
thumbnail
Congress Presentation
Clinical outcomes in patients with ischemic versus non-ischemic cardiomyopathy after angiotensin-neprilysin inhibition therapy
20 May 2023
thumbnail
Congress Presentation
Clinical characteristics and long-term outcomes of patients with heart failure with supra-normal ejection fraction: data from LECRA-HF registry.
30 August 2024
thumbnail
Congress Presentation
The odyssey to dethrone LV Ejection Fraction continues: the prognostic value of LV Global Function index in Heart Failure
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources